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Edited by Veli-Pekka LehtoAbstract Hypoxic environment in solid tumor is known to favor
cell survival and to initiate the formation of new capillaries. In
this work, we identiﬁed by 2D gel analysis 94-kDa glucose-reg-
ulated protein (GRP94) as being upregulated in human endothe-
lial cells in response to hypoxia. Three putative hypoxia
responsive elements (HRE) were found in the GRP94 promoter.
Competition experiments of HIF-1 DNA binding using speciﬁc
probes containing each HRE sequence of the GRP94 promoter
clearly evidenced that HIF-1 binds these sequences with high
aﬃnity. The human GRP94 promoter was then cloned upstream
of the luciferase gene and showed enhanced activity in hypoxic
conditions. Mutation of two of the three HREs present in this
promoter completely inhibited the hypoxia-induced increase in
luciferase activity.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Promoter1. Introduction
Tumor cell adaptation to hypoxic stress is required for tu-
mor growth. Indeed, when the nodule reaches 1-mm3, oxy-
gen diﬀusion from adjacent capillaries becomes limiting. In
response to this low oxygen level, tumors induce the develop-
ment of new blood vessels by a complex and multistep mech-
anism known as neo-angiogenesis. The early stage of this
response is mainly regulated by one hypoxia-sensitive tran-
scription factor, the hypoxia-inducible factor-1 (HIF-1),
composed of two subunits, HIF-1a and arylhydrocarbon
receptor nuclear translocator (ARNT) [1]. In hypoxic condi-
tions, HIF-1 increases the expression of these genes, leading
to the adaptive response of cells and tissues to oxygen deﬁ-
ciency [2].
On the other hand, cells respond to environmental and
physiological stresses through the induction of speciﬁc pro-*Corresponding author. Fax: 32 81 724135.
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ulated proteins (GRPs) [3–5]. GRP94, also known as gp96 or
tumor rejection antigen 1 (TRA1), is a member of the heat
shock protein 90 (HSP90) family and exhibits chaperoning
activity [6]. It is mainly localized in the lumen of the endo-
plasmic reticulum (ER) [7–10]. In addition to this main func-
tion, GRP94 has been shown to display antiapoptotic
properties [11,12] but the relationship between this protein
and the apoptotic machinery remains unclear. GRP94 pro-
moter contains several endoplasmic reticulum stress elements
(ERSE), which are responsible for the enhanced expression
of GRP94 under stress conditions. It has to be noted that
overexpression of GRP94 has been reported in human lung
cancer [13], in rat esophegal adenocarcinoma [14] and in hu-
man breast cancer cell lines [15].
Endothelial cells are the main cell type involved in neo-
angiogenesis. During their migration from capillaries toward
the tumor, these cells undergo various stress conditions
including hypoxia and acidic pH. In order to better under-
stand how these cells adapt to this challenging environment,
a proteomic analysis was performed on endothelial cells ex-
posed in vitro to hypoxic conditions. Several proteins were
identiﬁed to be overexpressed among which was GRP94.
This work also evidences that HIF-1 regulates GRP94
expression under hypoxia.2. Materials and methods
2.1. Cell culture
Human endothelial EAhy926 cells [16] were maintained in high
glucose Dulbeccos modiﬁed Eagles medium and HepG2 cells in
DMEM, both supplemented with 10% fetal calf serum. For hypoxia
experiments (1% O2), subconﬂuent cells were incubated in serum-free
CO2-independent medium (Invitrogen) supplemented with 1 mM
glutamine.
2.2. Two-dimensional electrophoresis
Subconﬂuent EAhy926 cells were incubated 16 h under normoxia or
hypoxia. After the incubation, cells were washed with ice-cold phos-
phate-buﬀered saline (PBS) and lysed with a buﬀer containing 7 M
urea, 2 M thiourea, 4% CHAPS, 60 mM dithiothreitol (DTT), 2%
Pharmalyte (Amersham), and Complete (Roche). Lysates were centri-
fuged for 10 min at 13000 · g and supernatants were stored at 70 C.
For two-dimensional electrophoresis, proteins (100 lg) were ﬁrst sep-
arated by isoelectric focusing in IPG gels, pH 4–7, using IPGphor
(Amersham). First-dimension gels were attached to the top of 10%blished by Elsevier B.V. All rights reserved.
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System (Amersham). For analyses, gels were silver-stained. Semi-quan-
titative analyses of protein levels of silver-stained gels from three inde-
pendent cultures were performed using Image Master 2D Elite v4.01
software (Amersham Pharmacia Biotech).
2.3. Q-TOF mass spectrometry
Washing steps and digestion were performed according to a proce-
dure modiﬁed from Shevchenko et al. [17]. Peptides were extracted
using water and acetonitrile followed by 5% formic acid and then ace-
tonitrile. The dried samples were reconstituted in 5% formic acid and
desalted on stage tips (Proxeon) before being loaded into the nano-
spray capillary needles (Waters). Mass measurements were performed
on a Micromass Q-Tof2 mass spectrometer with the MaxLynx3.5 soft-
ware. MS acquisitions were performed within the mass range of 500–
1300 m/z and MS/MS spectra within 20–2000 m/z.
2.4. Immunoﬂuorescence
EAhy926 cells were seeded on a glass coverslip. After16 h under nor-
moxia or hypoxia, cells were ﬁxed, permeabilized and labeled with the
primary antibody (anti-GRP94 antibody, SPA-850 Stressgen Biotech-
nologies Corp.; anti-calnexin, Stressgen; anti-GM130, BD Transduc-
tion Laboratory, dilution 1/100) as previously described [18]. Semi-
quantitative observations were performed in a confocal microscope
with a constant photomultiplier value.
2.5. Extraction of RNA and cDNA synthesis
Preparation of total RNA was performed using RNAgent kit
according to the manufacturers instructions (Promega). mRNA were
then retrotranscribed into cDNA using oligodT primers and Super-
script II reverse transcriptase kit according to the manufacturers
instructions (Invitrogen).
2.6. Real-time PCR analysis
The levels of GRP94 or aldolase transcripts were determined by real-
time reverse transcriptase (RT)-PCR using SYBRGreen. To normalize
for input load of cDNA between samples, a-tubulin was used as an
endogenous standard. Speciﬁc primers were used: GRP94 forward 5 0-
TTGCCAGACCATCCGTACTG-3 0; GRP94 reverse 5 0-GAATT-Fig. 1. Comparison of protein expression pattern in lysates from cells incub
polyacrylamide gel electrophoresis of lysates obtained from EAhy926 cells
peptidic sequences of the 94-kDa protein to the one of human GRP94. T
determined by tandem mass spectrometry.GGATGAAAGATAAAGCCCTTA-3 0; aldolase forward 5 0-GAATT-
GGATGAAAGATAAAGCCCTTA-3 0; aldolase reverse 5 0-TTGCC-
AGACCATCCGTACTG-30; a-tubulin forward 5 0-CCCGAGGG-
CACTACACCT-3 0, and a-tubulin 5 0-CAGGGAGGTGAACCCAG-
AAC-3 0 as the reverse primer. cDNA was added to SYBR Green Mas-
ter Mix PCR. PCRs were carried out in a real time PCR cycler (ABI
PRISM 7700 Sequence Detector, PE Applied Biosystems). Thermal cy-
cling conditions were: initial incubation of 10 min at 95 C, followed by
40 cycles of 30 s at 95 C, 1min at 57 C annealing temperature, and 30 s
at 72 C. Samples were compared using the relative Ct method [19].2.7. Western blot analysis
Subconﬂuent EAhy926 cells were incubated under normoxia or
hypoxia, and, at the indicated time points, cells were washed with
ice-cold PBS and lysed as previously described for two-dimensional
electrophoresis. Samples were applied to 10% NuPAGE Bis-Tris gels
(Invitrogen), according to the manufacturers instructions and then
transferred to Hybond PVDF membrane. Membranes were blocked
overnight at 4 C in TBS-T solution containing 20 mM Tris, 140
mM NaCl, 0.1% Tween 20, pH 7.6, 3% non-fat dried milk. Then,
membranes were probed with monoclonal anti-GRP94 antibody
(dilution 1/5000). Proteins were visualized by ECL. Membranes were
reprobed with a-tubulin antibody (dilution 1/100000, Sigma) for
normalization.
2.8. Preparation of nuclear extracts
Cells were washed with ice-cold PBS containing 1 mM Na2MoO4
and 5 mM NaF. Then, cells were incubated for 3 min with ice-cold
hypotonic buﬀer (HB) containing 20 mM HEPES, pH 7.9, 5 mM
NaF, 1 mM Na2MoO4, and 0.1 mM EDTA. Cells were harvested in
HB containing 5% NP-40. Lysates were centrifuged for 30 s at
13000 · g. Pellets were dissolved in 50 ll of RE buﬀer, composed of
HB containing 20% glycerol, 4% PIC, and 4% PIB (25 mM NaVO3,
250 mM phospho-nitrophenyl phosphate, 250 mM a-glycerophos-
phate, and 125 mMNaF). Then, 50 ll of SA buﬀer, composed of RE
buﬀer containing 400 mM NaCl, was added. Samples were placed at
4 C for 30 min under gentle rotation for nuclear protein extraction.
Then, samples were centrifuged for 10 min at 13000 · g at 4 C and
supernatants were stored at 70 C.ated under normoxia or hypoxia. (A) Silver-stained two dimensional
incubated for 16 h under normoxia or hypoxia. (B) Comparison of
he amino acid sequences of the protein upregulated by hypoxia were
Fig. 2. Time-course analysis of GRP94 protein level during hypoxia in EAhy926 cells. Analysis of GRP94 protein level in total extracts from
EAhy926 cells incubated under normoxia (N) or hypoxia (H) for the indicated periods of time. GRP94 protein level was analyzed by Western blot,
and densitometric values were normalized to the a-tubulin band and expressed as percentage expression compared to control cells maintained in
normoxia.
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HIF-1 DNA binding activity was measured using a colorimetric as-
say (Trans-AM) developed in our laboratory [20] and sold by Active
Motif. Assays were performed according to the manufacturers instruc-
tions. For competition, wild-type and mutated oligonucleotides corre-
sponding to HRE sequences of TRA1 promoter were synthetized
according to the sequence of the human TRA1 promoter (GenBank
Accession No. M33716) [10], and were introduced in variable fold ex-
cess in binding buﬀer, prior to the addition of the nuclear extract. HIF-
1 binding to the erythropoietin HRE sequence linked to the wells was
revealed with an anti-HIF-1a antibody at a ﬁnal dilution of 1/1000
(BD Transduction Laboratory).2.10. TRA1 promoter cloning and site-directed mutagenesis
A DNA fragment encoding the human TRA1 promoter was cloned
into the pGL3-enhancer vector (Promega) upstream of the ﬁreﬂy lucif-
erase gene (Fig. 8, left panel). This fragment was ampliﬁed from
HepG2 genomic DNA by PCR using primers with KpnI or BglII link-
ers 5 0-ggggtaccccATGGAGATCCTGGAATAGGCA-30 (KpnI linker
underlined) and 5 0-gaagatcttcTGAGTCTCAAGTCCCCTTCGA-3 0
(BglII linker underlined). The PCR consisted of 30 cycles of 30 s at
94 C, 1 min at 50 C, and 2 min at 72 C. PCR was preceded by 2
min at 94 C and followed by 10 min at 72 C. The resulting amplicon
starts at nucleotide 799 and ends at nucleotide +91 of the human
TRA1 promoter [10] (Fig. 3). The resulting vector was named pGL3-
PromTRA1.
Mutations in each of the three putative HRE sites were intro-
duced into the pGL3-PromTRA1 vector using an oligonucleotide-di-
rected mutagenesis system (QuickChange Site-directed Mutagenesis
kit, Stratagene) according to the manufacturers instructions, using
the primers 5 0-GGGCTCTGGCAAAGACACGCTGGGGGAAAA-
TAAAGAAAGGGCCAAAACTACGC-3 0 and the reverse sequence
for HRE1, 5 0-GGAAAGGGTGAAGAATATTTTGCCATGGCT-
ACCGTTT-3 0 and the reverse sequence for HRE2, 5 0-GGCAAA-
GGGGCGGTCCCAAATATGAGGGGCCCGCGGAGCC-3 0 and
the reverse sequence for HRE3/4 (mutations underlined).2.11. Transient transfection and luciferase activity measurement
To assay transcriptional activity of HIF-1, the pGL3-SV40/6HRE
reporter vector containing an artiﬁcial promoter with TATA box
and six copies of the erythropoietin HRE cis-element upstream of
the ﬁreﬂy luciferase gene was used as a hypoxia responsive positive
control. 3 lg DNA was transfected using Superfect reagent procedure
according to the manufacturers instructions (Qiagen) with the ratio
DNA-Superfect 1/2. Brieﬂy, the day before transfection, 5 · 104
HepG2 cells were seeded in 24-well culture plates. The DNA mix con-
taining 1/13 pRL, 2/13 of the reporter plasmid, and 10/13 of
pCMVmyc was delivered to cells for 4 h. Sixteen hours post-transfec-
tion, cells were incubated under normoxia or hypoxia for 8 h. Lucifer-
ase activity measurements were performed in a luminometer using
Dual Luciferase Reporter Assay System (Promega).3. Results
3.1. Identiﬁcation of one 94-kDa protein induced by hypoxia
Two-dimensional gel electrophoresis, to detect proteins newly
synthesized or upregulated in response to hypoxia in human
endothelial cells, was performed on total cell lysates from
EAhy926 cells incubated for 16 h under hypoxia. The density
of one protein spot with a molecular mass of about 94-kDa
was found to be increased in comparison to normoxic control
(Fig. 1A). The result presented in Fig. 1A is representative of
three independent experiments. This protein was identiﬁed
using tandem mass spectrometry technique as described in Sec-
tion 2. The sequences of two peptidic fragments obtained from
the 94-kDa protein by trypsin digestion are identical to
residues 22–38 and 117–135 of the human 94-kDa glucose-reg-
ulated protein (GenBank Accession No. NP_003290) (Fig.
1B).
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hypoxia-incubated endothelial cells
In order to conﬁrm the data obtained in 2D gel electropho-
resis, we performed a time-course analysis of GRP94 protein
expression from EAhy926 cells incubated under normoxia or
hypoxia (Fig. 2). In comparison to normoxia, GRP94 level
was increased up to 270% in EAhy926 cells incubated under
hypoxia for 2 h. The GRP94 protein level then decreased to in-
crease again after 6 h reaching 390% after 24 h of hypoxia and
180% after 40 h of hypoxia (Fig. 2). Low glucose concentration
(1 g/l compared to 4.5 g/l in control cells) markedly increased
GRP94 protein level in a time dependent manner (data not
shown).3.3. Immunoﬂuorescence analysis of GRP94 in endothelial cells
under hypoxia
In order to conﬁrm the overexpression of GRP94 and to
determine its subcellular localization, immunoﬂuorescence
studies were performed using speciﬁc monoclonal antibodies
against GRP94 and against calnexin, a protein localized inFig. 3. Immunoﬂuorescence analysis of GRP94 expression in hypoxia vs. n
hypoxia. After the incubation, cells were ﬁxed, permeabilized and stained for
(red, A), or GM130, a protein localized in the Golgi apparatus (red, B).
photomultiplier. Nuclei were stained with TOPRO-3 (blue, A).the ER or GM130, a protein localized in the Golgi apparatus.
An increased staining for GRP94 was observed in cells incu-
bated for 16 h under hypoxia (Fig. 3). Co-localization experi-
ments showed that GRP94 had the same localization than
calnexin, both in normoxic and hypoxic conditions (Fig.
3A). On the contrary, in both conditions, GRP94 did not co-
localize with GM130 (Fig. 3B). In addition, no GRP94 could
be observed on the plasma membrane. These studies suggest
that hypoxia does not induce a relocalization of GRP94.3.4. Time-course analysis of GRP94 mRNA level in hypoxia-
incubated endothelial cells
To determine whether GRP94 protein overexpression during
hypoxia corresponds to an increase in GRP94 encoding gene
transcription, we performed a time-course analysis of GRP94
mRNA levels (Fig. 4A). The GRP94 mRNA level was in-
creased to 150% in EAhy926 incubated under hypoxia for 1
h, compared to normoxic cells. It then decreased after 3 h of
hypoxia. Then, the levels of GRP94 mRNA increased to
240% after 24 h of hypoxia, then decreased again to 170% afterormoxia. EAhy926 cells were incubated for 16 h under normoxia or
GRP94 (green, A; red, B) and calnexin, a protein localized in the ER
Cells were then observed in confoncal microscopy with a constant
S. Paris et al. / FEBS Letters 579 (2004) 105–114 10940 h of hypoxia (Fig. 4A). Similar results were obtained in two
independent experiments. It has to be noted that this biphasic
induction was similar for GRP94 protein and mRNA levels.
This mRNA expression proﬁle was compared to the one for
aldolase (Fig. 4B), a protein known to be upregulated by HIF-
1 in hypoxia [21]. Time-course analysis of aldolase mRNA lev-
els revealed of proﬁle similar to the one observed for GRP94
mRNA levels, with an early peak of transcription (with a delay
when compared to GRP94), and a high level of expression
after 16 h.
3.5. Bioinformatic analysis of the GRP94 promoter
Bioinformatic analysis of the promoter of the human TRA1
gene encoding GRP94 (GenBank Accession No. M33716)
has been performed to search for the DNA sequence 5 0-
ACGTG-3 0 corresponding to the hypoxia-response element
(HRE), which is the HIF binding site. We identiﬁed four puta-
tive HRE sequences located at –702-bp (HRE1), –408-bp
(HRE2, inverted), –249-bp (HRE3, inverted), and –245-bp
(HRE4, overlapping HRE3) (Fig. 5). An additional HRE se-
quence was identiﬁed in the ﬁrst intron (HRE5) of the TRA1
gene, located at +229-bp (Fig. 5). Three endoplasmic reticulum
stress elements (ERSE) with the conserved sequence 5 0-
CCAAT-(N9)-CCACG-3
0 [22] have also been found at –196-
bp, –137-bp, and –72-bp as previously described by Roy and
Lee [23].A
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Fig. 4. Time-course analysis of GRP94 mRNA level during hypoxia in E
determined by real-time RT-PCR analyses. Cells were incubated under norm
aldolase mRNA levels were calculated as the ratio of GRP94 or aldolase e
normalized to a-tubulin levels.3.6. Time-course analysis of HIF-1a protein level and HIF-1
DNA binding activity
To determine if the overexpression of GRP94 mRNA level
under hypoxia could be correlated with the activity of HIF-
1, we performed a time-course analysis of HIF-1 protein level
by Western blot. The presence of HIF-1a was observed in ly-
sates from cells incubated under hypoxia, but not in normoxic
cell lysates (Fig. 6A). Stabilization of HIF-1a occurred rapidly,
already after 1 h incubation.
HIF-1 DNA binding activity toward the erythropoietin
HRE sequence was then measured using a Trans-AM assay
(Fig. 6B). Time-course analysis of HIF-1 DNA binding activ-
ity showed that HIF-1 was able to bind the erythropoietin
HRE sequence already after 1 h incubation; this activity
peaked after 3 h. This activity was maintained at a high level
up to 24 h incubation.
3.7. Binding of HIF–1 to the GRP94 promoter HRE sequences
To determine if HIF-1 binds to the putative HRE sequences
identiﬁed in the GRP94 promoter, competition experiments
were performed using nuclear extracts from cells incubated
for 4 h under hypoxia. Increasing fold excesses of wild type
or mutated probes for each HRE site of the GRP94 promoter
were used (Fig. 7A). The results showed an important decrease
in HIF-1 binding to the erythropoietin HRE linked into the
wells when soluble HRE1, HRE2, or HRE3/4 probes are94
6 8 1 6 2 4 40
olase
6 8 1 6 2 4 40
e (h)
e (h)
Ahy926 cells. Levels of GRP94 (A) and aldolase (B) mRNA were
oxia or hypoxia for the indicated periods of time. Relative GRP94 or
xpression in hypoxia incubated cells to those in normoxic cells, both
110 S. Paris et al. / FEBS Letters 579 (2005) 105–114added (Fig. 7B). Equimolar amounts of HRE1, HRE2, or
HRE3/4 probes led to 50% inhibition of HIF-1 binding (Fig.
7B). The inhibition of HIF-1 DNA binding to the erythropoi-
etin HRE increased when increasing excesses of each soluble
probe were added. At 50-fold excess, HRE1, HRE2 and
HRE3/4 seemed more eﬃcient than the positive control
W18, containing the erythropoietin HRE. Interestingly, no de-
crease could be observed for the HRE5 probe, up to 5-fold ex-
cess. An inhibition similar to the one obtained with the other
HREs was obtained only at 30-fold excess (Fig. 7B), suggesting
that HIF-1 binds to this sequence with a much weaker aﬃnity.
The speciﬁcity of the binding was conﬁrmed using mutated
probes. The mutations introduced in the diﬀerent HRE se-
quences have been previously reported to destabilize HIF-1/
HRE binding [24]. Increasing excesses of the mutated probes
for HRE1, HRE2, or HRE3/4 sequences did not aﬀect HIF-
1 binding on the erythropoietin HRE sequence (Fig. 7B).
These results suggest that HIF-1 speciﬁcally binds each of
the three HRE sequences localized in the GRP94 promoter
and only weakly the HRE sequence present in the ﬁrst intron.
3.8. Analysis of the GRP94 promoter activity
The activity of the GRP94 promoter was then investigated.
HepG2 cells were used for these experiments because of their
higher transfection eﬃciency. GRP94 is also overexpressed in
HepG2 cells after 24 h incubation under hypoxia (data not
shown). A 891-bp fragment of this promoter was cloned inFig. 5. Analysis of the human GRP94 promoter. The promoter of the hu
sequences. One additional HRE sequence (HRE5) is present in the ﬁrst i
orientation of the HRE or ERSE sequences. The promoter sequence is indi
letters, exon I is indicated in bold capital, and ﬁrst intron in small bold letters.
used for Trans-AM competition assays. Arrows indicate the sequence of the
position relative to the transcription initiation site.the reporter pGL3 plasmid encoding the ﬁreﬂy luciferase.
Using pGL3-SV40/6HRE vector as a positive control, a 2.7-
fold increase in the luciferase activity was observed under hy-
poxia (Fig. 8), compared to normoxia. No signiﬁcant luciferase
activity could be observed for empty pGL3 neither under nor-
moxia nor under hypoxia (data not shown). pGL3-PromTRA1
displayed a high luciferase activity in normoxia, indicating a
strong basal activity. In addition, hypoxia induced a 2-fold in-
crease in luciferase activity (Fig. 8). In normoxia, the luciferase
activity observed for the wild-type promoter was dramatically
decreased when HRE1 or HRE3/4 but not HRE2 was mu-
tated. In addition, there was no longer an induction by hypox-
ia of the luciferase activity with one or the other mutation.
Despite a marked induction of luciferase activity under hypox-
ia compared to normoxia for MutHRE2, a 50% decrease in
luciferase activity could be observed compared to the wild-type
promoter (Fig. 8). These results indicate that HRE1 and
HRE3/4 play an important role in the hypoxia-induced in-
crease in the GRP94 promoter activity.4. Discussion
GRP family proteins are well known to be upregulated by
several stresses such as glucose starvation [25] or Ca2+ iono-
phore A23187 [26]. By using two-dimensional gel electrophore-
sis analysis of lysates from cells incubated for 16 h underman TRA1 gene, encoding the GRP94 protein, possesses three HRE
ntron. Three putative ERSE were also identiﬁed. Æandæ indicate the
cated in capitals, 5 0UTR sequence of the mRNA is indicated in small
Framed letters indicate HRE sequences. Gray ﬁelds indicate sequences
primers used for cloning the promoter. Numbers indicate nucleotide
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endothelial cells. An increase in GRP94 protein expression
has been previously observed in HEK cells incubated under
hypoxia [27] or in rat astrocytes exposed to hypoxia-reoxygen-
ation [28], but, to our best knowledge, it is the ﬁrst time that
such an overexpression is observed in human endothelial cells.
Time-course analyses of GRP94 protein and mRNA levels
were performed. A biphasic increase was observed with peaks
at 1–2 and 24 h. The kinetics of GRP94 protein and mRNA
levels observed in this work is similar to the one shown by
Graven et al. [29] for the protein disulﬁde isomerase (PDI), an-
other ER chaperone protein, overexpressed in hypoxic condi-
tions. The similarity between GRP94 protein and mRNA
levels suggests an increase of GRP94 translation due to an in-
crease in mRNA levels rather than a stabilization of the pro-
tein under hypoxia, but this requires further investigation.
Immunoﬂuorescence analyses conﬁrm that GRP94 is local-
ized in the ER under normoxia, as previously described [30–
32]; indeed, GRP94 co-localized with calnexin, a well-known
resident protein of the ER. They also evidenced that hypoxia
did not induce a relocalization of GRP94 to the Golgi appara-
tus [30], to the nucleus [33], or to the plasma membrane [34], as
previously observed for other types of stress. This suggests that
relocalization of GRP94 to other organelles requires mecha-
nisms diﬀerent from the one responsible for the overexpression
of GRP94 in response to hypoxia.
The increase in GRP94 mRNA level was probably due to
transcription regulation as already observed in K12 cells incu-
bated in the presence of b-mercaptoethanol [35]. Several puta-
tive HRE sequences were indeed identiﬁed in the promoter of
the TRA1 gene. Interestingly, although human GRP78/Bip
protein, another member of the GRP family present in theFig. 6. Time course analysis of HIF-1a protein level and HIF-1 DNA
binding activity during hypoxia. (A) Time course analysis by Western
blot of HIF-1a protein level from EAhy926 cells incubated under
normoxia (N) or hypoxia (H) for the indicated periods of time. a-
tubulin was used as loading control. (B) Colorimetric analysis of HIF-
1 DNA binding activity. Nuclear extracts from EAhy926 cells
incubated under normoxia or hypoxia for the indicated periods of
times were incubated in the presence of HRE sequence linked into a
well. HIF-1 binding was detected using an anti-HIF-1a antibody.
Results are means ± S.D. (n = 3).ER, is coordinately regulated under a variety of stress condi-
tions with GRP94 [36], and known to be overexpressed under
hypoxia [37], no HRE sequence was detected in its promoter
(GenBank Accession No. X59969, data not shown). Other
ER proteins such as ORP150 that do no possess HRE se-
quence in their promoter have similarly been reported to be
overexpressed under hypoxia [38]. This suggests that GRP78/
Bip and ORP150 overexpression in response to hypoxia may
be HIF-1 independent.
The role of the diﬀerent HRE sequences present in the
GRP94 promoter in the hypoxia-induced overexpression of
this protein was studied. Time-course analysis of HIF-1a pro-
tein level and DNA binding activity during hypoxia in
EAhy926 cells were performed. A rapid activation of HIF-1
was demonstrated, as early as 1 h. Trans-AM competitions
for HIF-1 DNA binding activity showed that HIF-1 binds
all the three TRA1 promoter HRE sequences with high aﬃn-
ity. Since the competition was better with HRE1, HRE2 or
HRE3/4 than with W18, this aﬃnity was at least as high as
with the erythropoietin HRE [24]. This binding is HIF-1 spe-
ciﬁc, since mutations known to destabilize HIF-1 binding to
the W18 probe [24] in the three GRP94 promoter HREs also
prevented competition.
Transient transfection of a reporter plasmid containing the
wild-type TRA1 promoter showed a high luciferase activity un-
der normoxia, indicating a high basal activity. High constitu-
tive expression of GRP94 and GRP78/Bip proteins has been
reported [4,9] and this observation is consistent with the role
of these proteins as molecular chaperones. A 1.9-fold increase
in luciferase activity was observed under hypoxia. This result is
in good agreement with the 160% increase in GRP94 mRNA
observed after 8 h incubation. Under normoxia, mutation of
HRE1 or HRE3/4 led to a dramatic decrease in the luciferase
activity. Such a decrease in the basal activity under normoxia
after mutating a HRE sequence has previously been observed
for enolase-1 [21], another gene whose expression is regulated
by HIF-1. Moreover, no increase in luciferase activity could be
observed under hypoxia when one or the other of these muta-
tions was present, indicating that these two HRE sequences are
required for the increased transcriptional activity. Interest-
ingly, the lack of luciferase activity induction under hypoxia
for HRE1 or HRE3/4 mutations suggests that the induction
of GRP94 promoter under hypoxia is ERSE independent. In-
deed, if hypoxia were triggering the UPR response through
these ERSEs in the GRP94 promoter, an increased luciferase
activity should still be observed, because these mutations do
not aﬀect any of the three ERSEs. Recently, activation under
hypoxia of the GRP78 promoter independently of the ERSEs
was reported in NIH-3T3 cells [39], which is in agreement with
our results for GRP94. Mutation of HRE2 has no eﬀect on the
basal activity of the TRA1 promoter under normoxia, but led
to an important decrease in the transcriptional activity under
hypoxia. This indicates that HIF-1 could bind HRE2 in hyp-
oxic conditions and that this binding participates to the tran-
scription of TRA1 promoter in these conditions. Altogether,
these results suggest a complex regulation of the TRA1 pro-
moter under hypoxia. The biphasic response observed here
for GRP94 mRNA could be explained by the intervention of
diﬀerent transcription factors, such as already reported for c-
jun expression in HepG2 cells incubated under hypoxia [40].
In this study, Laderoute et al. demonstrated that the
hypoxia-inducible c-jun mRNA expression has an early
Fig. 7. HIF-1 DNA-binding activity toward GRP94 promoter HREs. (A) Wild-type and mutated probes used in a competition binding assay for
HIF-1. HRE sequences framed, mutations underlined. (B) HIF-1 DNA-binding competition. Wild type (gray) or mutated (hatched) probes were
used for competition at indicated fold excess. Nuclear extracts were obtained from EAhy926 cells incubated for 4 h under hypoxia (gray and hatched
bars) or normoxia (open bars). CTL, control. W18 probe was used as positive control. Results are means ± S.D. (n = 3).
112 S. Paris et al. / FEBS Letters 579 (2005) 105–114response (30 min) that is independent of HIF-1 and a late re-
sponse (6–8 h) that requires its presence. A similar kinetic
was observed here with an early peak for mRNA at 1h andLucpGL3-PromTRA 1
LucpGL3-MutHRE1
LucpGL3-MutHRE2
LucpGL3-MutHRE3/4
LucpGL3-SV40/6HRE
Fig. 8. Functional analysis of the human GRP94 promoter. HepG2 cells we
pGL3-SV40/6HRE and pRenilla as the normalization plasmid. Cells were the
were measured. Wild type HRE sequences in black. Mutated HRE sequencefor protein expression at 2 h and a later induction increasing
from 8 to 24 h for both. Although our experiments had evi-
denced that HIF-1 plays a role in GRP94 overexpression un-50403020100
relative ratio Firefly/Renilla
Normoxia
Hypoxia
re transfected with one of the diﬀerent GRP94 promoter constructs or
n incubated under normoxia or hypoxia for 8 h and luciferase activities
s in gray. Results are means ± S.D. (n = 3).
S. Paris et al. / FEBS Letters 579 (2004) 105–114 113der hypoxia, it remains to be elucidated when HIF-1 is actually
required. The results obtained with the reporter system indi-
cate that HIF-1 is certainly involved but do not resolve yet
the exact kinetic of the hypoxia-induced increase in the
GRP94 promoter activity.
GRP94 has been reported to be overexpressed in diﬀerent
forms of cancer. It has been postulated that this overexpres-
sion enhances tumor cell survival, since a protective eﬀect of
GRP94 against hypoxia-induced apoptosis has been shown
[41]. Furthermore, induction of overexpression of GRP94 in-
creases drug resistance [42–44]. Similarly, the upregulation of
GRP94 observed here in endothelial cells exposed to hypoxic
conditions may participate to cell protection when these cells
migrate into poorly vascularized tumors. Not only hypoxia
per se but also glucose starvation and/or acidic conditions, typ-
ical of tumor environment are potent physiological inducers of
the GRP94 promoter [45]. Upregulation of GRP94 in tumors
and in new capillaries may thus be one more mechanism by
which hypoxia enhance tumor growth and progression.Acknowledgements: We thank Dr. Edgell (Department of Pathology
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